Avidity Biosciences, Inc.’s Post

Wrapping up a successful #JPMWeek, we are more energized than ever by the momentum driving Avidity’s mission to profoundly impact the lives of patients. #JPM2025 highlighted the exponential growth opportunities ahead as we prepare for a transformative year. As part of this forward momentum, Eric Mosbrooker is expanding his role to Chief Commercial Officer. Eric has been a driving force behind Avidity’s strategic vision, playing a key role in expanding our pipeline and laying the groundwork for future success. In his new role as CCO, Eric will be focused on strengthening our commercial strategy, building a global infrastructure to support our growing footprint, and accelerating the delivery of our AOCs to patients. His leadership will be integral as we enter this exciting next chapter, turning our vision into tangible, meaningful impact for those who need it most. Learn more in our press release: https://lnkd.in/ejebVCsE

  • No alternative text description for this image
John J Collins MBA

Co-Founder MedInsights Unleashed/ Global Business and Marketing Strategist in Oncology

1w

Eric congratulations, well deserved🔥I’m very excited for you and the team at Avidity . All the very best to the family , be safe mate and enjoy the experience.

Like
Reply
Michael Marino

President & CEO, Big Arrow Group | Where Creative Means Business

5d

I can say I knew you when. All the best!

Like
Reply
Samuel Lee

Senior Director, IT Infrastructure & Operations at Allakos Inc

1w

Congratulations on your new role!

Like
Reply
Like
Reply
Jennifer Vito

Patient Support Services Development & Operations in Oncology, Specialty and Rare Disease

1w

Best of luck. Congratulations Eric.

Like
Reply
Barry Flannelly

Executive Vice President, General Manager – North America at Incyte | Leading a team of innovators to address unmet patient needs

2w

Well done

Like
Reply
C. Rick Jarecke, PharmD

Biotech Expert- Field Medical Affairs Pre and Post Commercialization

2w

Congrats, Eric! This transformative year is exciting for many reasons.

Mallika Ann Ambat

Rare Disease Insights Leader at Johnson and Johnson Innovative Medicine

2w

Congratulations Eric Mosbrooker! Avidity Biosciences, Inc. is lucky to have you driving their transformation!

Carolina Alarco

Biotech/Medtech Executive and Board Member, Strategic Advisor, Venture Capital, Angel Investor

2w

Well done!!

Like
Reply
Michael Irgang

President at Global Risk Management

2w

Great news, Eroc! Congratulations.

Like
Reply
See more comments

To view or add a comment, sign in

Explore topics